We present a case of imported leishmaniasis in a 31-year-old woman from Slovakia, who visited the countries of South America for three months in 2011. On 29 and 31 August 2011, she was probably infected with Leishmania parasites in the jungles of Ecuador. Approximately one week after returning to Slovakia, a small papules appeared on patient's left leg. Another wound was found after two weeks. Both ulcers were enlarging. We proved amastigote forms of Leishmania spp. only in repeated dermal scrapings from the edge of the ulcer by Giemsa staining after negative results from examination of a wound scrape and biopsy specimen. We identifi ed the species Leishmania (Viannia) panamensis as a causative agent by using the polymerase chain reaction (PCR) method and subsequent sequencing of the ITS region. Closure of wounds and scab formation were observed after 20 days of treatment with sodium stibogluconate. In the control microscopic examination after the end of the treatment, parasites were not present, and the PCR confi rmed the negative result (Fig. 2 
Introduction
Leishmaniasis is a vector-born parasitic disease caused by several species of protozoan parasites of the genus Leishmania and transmitted by the bite of phlebotomine sandfl ies. It is endemic in 88 countries around the world, ranging from the tropics to the subtropics, including southern Europe. The number of human infections has reached about 12 million, with an annual incidence of two million new cases, and an additional 350 million people are estimated to be at risk (1) . There are two main clinical forms of leishmaniasis: (i) visceral (VL) and (ii) cutaneous (CL), which represents about 2/3 of all clinical cases. Cutaneous leishmaniasis in the New World is caused by protozoans of the genus Leishmania, which has been divided into two subgenera: Leishmania and Viannia. The reservoir of infection is a wide range of vertebrates, including humans (2, 3) . The most common clinical form of CL presents as single or multiple localised skin lesions. At the bite site, on the face, back, or extremities, CL starts as a painless, often itchy papule that ulcerates to a typical round-to-oval lesion with a necrotic and exudative centre surrounded by a raised margin. The lesions are usually painless but can be painful, especially if ulcerative lesions become infected with bacteria or if the lesions are near a joint. Sometimes lymphadenopathy is noticed fi rst, before skin lesions develop. The healing process typically results in atrophic scarring (4, 5) . Third, less common form of the disease, mucocutaneous leishmaniasis (MCL) develops in 1 -10 % of patients with localised CL caused by Leishmania or Viannia subgenera, mainly in Latin America (6, 7) . Therefore, the causative agent of CL imported from Latin America should be identifi ed before treatment. Diagnosis is confi rmed by a microscopic and cultivation evidence of the parasite from biopsies of skin lesions. Because Leishmania species are indistinguishable microscopically, differentiation is based on molecular, biological (polymerase chain reaction (PCR)) and biochemical techniques (8, 9, 10, 11) .
Autochthonous leishmaniasis is not found in countries located in the temperate climate zone, including Slovakia. To date, two cases of imported leishmaniasis in travellers returning from endemic areas have been documented in Slovakia (12, 13, 14) . We report a case of imported CL in a young traveller returning from Latin America.
Case report
A 31-year-old woman travelled through the countries of South America between 2 August and 14 October 2011. She spent 2 days in Bolivia, 10 days rafting in Peru, and one and a half months in Ecuador (from 16 August to 8 October 2011). During this period, she visited the jungles of Santo Domingo in the community Tsachilas for 3 days (from 29 to 31 August 2011). After this trip, she travelled back to Peru and Bolivia and returned to Slovakia. She had no health problems during the stay in South America. About a week after her return to Slovakia (on 21 October 2011), an ulcer of 2 cm in diameter developed from a small papule on her shin of the left leg in the distal calf. The ulceration was characterised by an increasing size, an intermittent yellowish discharge, and small crust on the surface. A new wound appeared at approximately 7 cm above the primary lesion, towards the knee (Fig. 1a) . She had a normal body temperature and the lesions were not itchy. On 16 November 2011, a local physician obtained biological specimens by scraping the edge of the lesions. No Leishmania parasites were found by microscopic examination of Giemsa-stained slides. The patient's serum did not show any haemagglutination activity in an indirect haemagglutination test for the detection of antibodies. Treatment with clindamycin was initiated due to a positive culture result for Staphylococcus aureus. Slightly elevated C-reactive protein (CRP; 8.58 mg/L; normal range 0-5 mg/L) and lipase levels (1.61 μkat/L; reference range 0.22-1.00 μkat/L) were detected by laboratory methods used in haematology and biochemistry. Complete blood count was normal except for slightly elevated monocytes. On 29 November 2011, a part of the wound (below the knee) was surgically excised for histological examination. The epidermis showed irregular acanthosis. Dilated capillaries and dense lymphocytic infi ltrate with an admixture of histiocytes were found in the upper and middle epidermis. The lower dermis and subcutis were not present. Infections of macrophages by amastigote forms of Leishmania spp. were not found in this sample. The dimensions of the lesions further increased. A pink-red painless plaque (5 cm long x 1 cm wide) appeared in the distal 1/3 of the posterior thigh. Swollen inguinal lymph nodes were not seen. The patient was transferred to our laboratory (HPL Ltd. Slovakia) due to persistent clinical suspicion for leishmaniasis. On 21 December 2011, we obtained biological specimens by scraping the edge of the lesion (Fig. 1b) , and showed amastigote forms of Leishmania spp. by Giemsa staining (Fig. 2a) .
The titres of haemagglutination activity of the patient's serum were borderline (1:16). A DNA sample from the patient's lesion was analysed by Leishmania-specifi c PCR amplifi cation using the primer pair of L5.8S and LITSR (15) , which amplifi es approximately 300-bp amplicon containing a partial sequence of the 18S ribosomal RNA gene, complete sequences of internal transcribed spacer 1 (ITS1) and a partial sequence of the 5.8S ribosomal RNA gene (Fig. 2b) . The fi nal PCR product was gel-purifi ed and sequenced using the BigDye Terminator version 3.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA) on 1c) . Skin lesions were treated with Betadine also. The patient had no complications after completing treatment, and was discharged into out patient care. On 1 April 2012 (3 weeks after treatment), the titres of haemagglutination activity of the patient's serum were 1:64 in the control serological test. Parasite DNA was not detected by PCR in the specimens scraped from healing wounds (Fig. 2b) . Two months after treatment, crusted lesions were no longer present. As typical, the healing process resulted in atrophic scarring that was visible 1 year after treatment (Fig. 1d) . On 17 May 2012, the titres of the patient's serum were reduced to borderline values (1:8) by haemagglutination assay in the follow-up examination, and on 17 December 2012, her serum was negative for haemagglutination antibodies.
Discussion
The increasing trends of global travel, especially to tropical and subtropical countries including South America, pose a higher risk of acquiring CL. An increasing number of CL cases in European travellers was demonstrated in some epidemiological studies. For example, during the last decade, an increasing number of imported CL cases was observed in English and Dutch patients who visited the aforementioned countries (16, 17) . The highest numbers of CL cases were recorded during a stay in rural and jungle areas. The 31-year-old Slovak traveller reported here was infected while visiting South America. She was probably infected with Leishmania by a sand fl y bite in the jungles of Santo Domingo (Ecuador). Native people informed the patient about the presence of leishmaniasis and its vector, phlebotomine sandfl ies of the genus Lutzomyia, in Ecuador. CL and MCL constitute a serious public health problem in Ecuador, since the diseases are endemic in 17 of 20 provinces (18) . The complex Leishmania (Viannia) panamensis/guyanensis is the predominant aetiologic agent of CL and MCL in Ecuador, and was the agent identifi ed in our patient. In addition to this complex, a further fi ve species of Leishmania have been recorded in Ecuador (1, 11, 19, 20) .
The diagnosis of CL is diffi cult due to the wide range of cutaneous manifestations. Differential diagnosis is necessary to distinguish CL from cutaneous malignancies, bacterial and fungal skin lesions, leprosy, tuberculosis, eczema, and myiasis, which could have similar symptoms (21, 22) . One should consider CL with moist non-healing papular or ulcerative progressive lesions on the skin in people residing in endemic areas. We observed these symptoms in our patient; therefore, we preferentially focused on the diagnosis of leishmaniasis. Although South American CL may be often accompanied by swollen lymph glands or secondary pustules on mucous membranes that should also be thoroughly investigated (16), we did not observe these symptoms in our patient. The patient did not suffer from fever and other examination results were normal except for a slightly elevated CRP.
The standard and still the most commonly used diagnostic method is microscopic examination of lesion material obtained by biopsy or scraping after Giemsa staining or after histological processing (4, 6). As we confi rmed in our patient, the success of diagnosis depends on correct sampling from the proper place on the lesion (23) . Histological examination of the sample from excision was not successful; we did not identify Leishmania parasites microscopically even in the fi rst specimens prepared from the ulcer. The amount of Gram+ cocci (probably secondary staphylococcal contamination) and leukocytes (PMN) in these preparations also indicated that the material was taken from an opened festering ulcer area where it was not possible to capture Leishmania, because they are destroyed by the immune response. We were able to detect Leishmania only in the repeated scalpel scrapes of the edge that surrounded the central necrotic ulcer area. However, amastigotes were found in such samples only occasionally. This confi rmed that in CL, parasites can only be detected in the area of infl ammatory skin lesion outside the necrotic tissue, and that the amount of Leishmania can be low and, therefore, requires careful microscopic examination. We carried out identifi cation of the species of parasites isolated from the patient and also used PCR for the verifi cation of the presence of parasites after the treatment. The PCR method together with sequencing can be used for the determination of a species-specifi c diagnosis because of the morphological similarity of Leishmania species (11, 17) , and eventually for monitoring treatment success (4) .
The aim of treatment of CL is to accelerate the healing of skin lesions and, in the case of New World CL caused by the Viannia subgenus, to prevent the invasion of the parasite into mucous membranes, usually of the oral or nasal cavities (5, 24) . For the treatment of New World CL, preparations with pentavalent antimony, Glucantime (which contains meglumine antimoniate), Pentostam (which contains sodium stibogluconate), pentamidine isethionate, or azole preparations, all administered parenterally, can be used (5, 16) . Miltefosine showed high in vitro activity against Leishmania (25, 26, 27) , a single drug against Leishmania that is administered orally (28, 29) . For our patient, we chose the overall treatment with sodium stibogluconate that is still one of the medications of choice for CL caused by the species of the L. (V.) guyanensis complex (21, 30) . Despite the described adverse drug reactions (17) , the patient tolerated the therapy without any problems. The 20-day treatment was successful, which was confi rmed by the negative PCR results and microscopic examination about a month after the treatment fi nished. Regular inspections showed no signs of relapse even after 1 year. In the literature, there are two records of imported leishmaniasis among Slovak citizens. The fi rst case was a CL acquired in Iraq in an adult patient (12) . The second case was a VL in a 13-month-old girl who was infected in Italy (13, 14) . In neither case was identifi cation of the Leishmania species performed, although the VL case may have been caused by Leishmania infantum, because the other species that causes the visceral form of the disease, Leishmania donovani, is not present in Europe (1, 31) .
Increasing travel opportunities for our citizens to endemic areas bring a considerable risk of serious infection with a broad spectrum of diseases, including CL. Therefore, it is necessary to extend the diagnosis of skin diseases with leishmaniasis for travellers with positive anamnesis.
